Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2C5H5N5.H2O4S |
Molecular Weight | 368.332 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.NC1=NC=NC2=C1N=CN2.NC3=NC=NC4=C3N=CN4
InChI
InChIKey=LQXHSCOPYJCOMD-UHFFFAOYSA-N
InChI=1S/2C5H5N5.H2O4S/c2*6-4-3-5(9-1-7-3)10-2-8-4;1-5(2,3)4/h2*1-2H,(H3,6,7,8,9,10);(H2,1,2,3,4)
Molecular Formula | H2O4S |
Molecular Weight | 98.078 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C5H5N5 |
Molecular Weight | 135.1267 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.drugbank.ca/drugs/DB00173Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25797921 | https://www.ncbi.nlm.nih.gov/pubmed/9046330 | https://www.ncbi.nlm.nih.gov/pubmed/2165159 | https://www.ncbi.nlm.nih.gov/pubmed/27776394 | https://www.ncbi.nlm.nih.gov/pubmed/26243842
Sources: https://www.drugbank.ca/drugs/DB00173
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25797921 | https://www.ncbi.nlm.nih.gov/pubmed/9046330 | https://www.ncbi.nlm.nih.gov/pubmed/2165159 | https://www.ncbi.nlm.nih.gov/pubmed/27776394 | https://www.ncbi.nlm.nih.gov/pubmed/26243842
Adenine is a nucleobase (a purine derivative). Its derivatives have a variety of roles in biochemistry including cellular respiration, in the form of both the energy-rich adenosine triphosphate (ATP) and the cofactors nicotinamide adenine dinucleotide (NAD) and flavin adenine dinucleotide (FAD). It also has functions in protein synthesis and as a chemical component of DNA and RNA. The shape of adenine is complementary to either thymine in DNA or uracil in RNA
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2096619 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2165159 |
85.8 µM [Ki] | ||
Target ID: CHEMBL308 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9046330 |
200.0 µM [IC50] | ||
Target ID: CHEMBL1929 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17379526 |
10.89 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | LEUKOTRAP WB SYSTEM Approved UseIndicated for collection of blood and preparation of red blood cells and plasma with pre-storage leukocyte reduction. Platelet concentrates are not intended to be made with this product. |
|||
Secondary | Unknown Approved UseUnknown |
|||
Secondary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Drug therapy for hepatitis B. | 2001 |
|
A novel polymorphism (-88 C>A) in the 5' UTR of the p53R2 gene. | 2001 |
|
A new Msp I polymorphism (g1741G>A) in intron 3 of the human delta-aminolevulinate dehydratase gene. | 2001 |
|
Metabolic fate of extracellular NAD in human skin fibroblasts. | 2001 |
|
Molecular characterization of monoamine oxidases A and B. | 2001 |
|
De novo mutation in the mitochondrial tRNALeu(UUR) gene (A3243G) with rapid segregation resulting in MELAS in the offspring. | 2001 Feb |
|
Origin of the cytoplasmic pH changes during anaerobic stress in higher plant cells. Carbon-13 and phosphorous-31 nuclear magnetic resonance studies. | 2001 Feb |
|
Differential actions of PKA and PKC in the regulation of glutamate release by group III mGluRs in the entorhinal cortex. | 2001 Feb |
|
Cloning, sequence analysis and heterologous expression of the DNA adenine-(N(6)) methyltransferase from the human pathogen Actinobacillus actinomycetemcomitans. | 2001 Feb 20 |
|
Mutagenic specificity of the base analog 6-N-hydroxylaminopurine in the LYS2 gene of yeast Saccharomyces cerevisiae. | 2001 Feb 20 |
|
Thermodynamics of ion-induced RNA folding in the hammerhead ribozyme: an isothermal titration calorimetric study. | 2001 Feb 6 |
|
Molecular and biochemical characterization of a cytokinin oxidase from maize. | 2001 Jan |
|
Inosine-5'-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells. | 2001 Jan |
|
A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. | 2001 Jan |
|
Phosphate exchange and ATP synthesis by DMSO-pretreated purified bovine mitochondrial ATP synthase. | 2001 Jan 15 |
|
2,8-Dihydroxyadenine urolithiasis in a patient with considerable residual adenine phosphoribosyltransferase activity in cell extracts but with mutations in both copies of APRT. | 2001 Mar |
|
Polymorphism of the WAF1 gene is related to susceptibility to cervical cancer in Japanese women. | 2001 Mar |
|
cAMP-independent phosphorylation activation of CFTR by G proteins in native human sweat duct. | 2001 Mar |
|
Role of adenosine kinase in Saccharomyces cerevisiae: identification of the ADO1 gene and study of the mutant phenotypes. | 2001 Mar 15 |
|
A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. | 2001 Mar 16 |
|
Specific labeling of the bovine heart mitochondrial phosphate carrier with fluorescein 5-isothiocyanate: roles of Lys185 and putative adenine nucleotide recognition site in phosphate transport. | 2001 Mar 30 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26243842
the daily dose of adenine is 10-60 mg/day
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25797921
NIH/3T3 cells were plated at a density of 2 × 106 cells and left untreated overnight, cultural media was exchanged and experimental plates were exposed to adenine (200 -1200 mkM) for 24 hr. Cells were counted at various concentration of adenine or AICAR with a hemocytometer after diluting the sample 1:1 with 0.4% trypan blue solution (Sigma-Aldrich, St. Louis, MO, USA). Alternatively, the cell cytotoxicity of the cells was monitored with XTT assay. 50 μL of XTT reagent was added and the plates were then incubated for 4 hr at 37 °C in the dark. The absorbance at 490 nm with a reference wavelength set at 690 nm using VersaMax ELISA microplate reader
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:09:07 UTC 2023
by
admin
on
Fri Dec 15 15:09:07 UTC 2023
|
Record UNII |
741GJF3K9M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
741GJF3K9M
Created by
admin on Fri Dec 15 15:09:07 UTC 2023 , Edited by admin on Fri Dec 15 15:09:07 UTC 2023
|
PRIMARY | |||
|
321-30-2
Created by
admin on Fri Dec 15 15:09:07 UTC 2023 , Edited by admin on Fri Dec 15 15:09:07 UTC 2023
|
PRIMARY | |||
|
DTXSID50883360
Created by
admin on Fri Dec 15 15:09:07 UTC 2023 , Edited by admin on Fri Dec 15 15:09:07 UTC 2023
|
PRIMARY | |||
|
206-286-5
Created by
admin on Fri Dec 15 15:09:07 UTC 2023 , Edited by admin on Fri Dec 15 15:09:07 UTC 2023
|
PRIMARY | |||
|
9449
Created by
admin on Fri Dec 15 15:09:07 UTC 2023 , Edited by admin on Fri Dec 15 15:09:07 UTC 2023
|
PRIMARY | |||
|
DBSALT002226
Created by
admin on Fri Dec 15 15:09:07 UTC 2023 , Edited by admin on Fri Dec 15 15:09:07 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |